Allied-Bristol Life Sciences LLC, a jointly owned enterprise between Allied Minds and Bristol-Myers Squibb Co., today announced that Satish Jindal, Ph.D., formerly Vice President of R&D within Bristol-Myers, has been appointed to lead the company's efforts to identify and foster development of biopharmaceutical innovations from top U.S. university research institutions. Jindal recently headed up Bristol-Myers' research and development center in Bangalore, India, that focuses on discovery and early development of drug candidates in several disease areas, including oncology, autoimmune diseases and fibrosis.
http://ift.tt/YVPEEC
http://ift.tt/YVPEEC
No comments:
Post a Comment